Table 5

Proportion of times that a drug-class ended up among the top three (in repeated simulations)

Mortality

Myocardial infarction

Stroke

Angina

Heart failure

Diabetes


Diuretics

18%

79%

46%

33%

99%

1%


BB

1%

2%

3%

38%

10%

9%


ACE

23%

75%

11%

27%

83%

96%


CCB

54%

36%

98%

51%

1%

62%


Alpha-blocker

25%

58%

9%

45%

0%

-


ARB

49%

5%

60%

22%

22%

99%


Diuretics and/or BB

84%

45%

71%

22%

65%

33%


"Conventional"

46%

0%

1%

-

20%

-


ACE, Angiotensin Converting Enzyme Inhibitors; ARB, Angiotensin Receptor Blockers; BB, Beta-blockers; CCB, Calcium Channel Blockers;

Fretheim et al. BMC Medicine 2012 10:33   doi:10.1186/1741-7015-10-33

Open Data